Gapping up
In reaction to strong earnings/guidance:
- BX +8.6%, URI +7.3%, SNA +4.9%, CNS +4.3%, ADTN +3.8%, STI +3.1%, LVS +2.9%, ETFC +2.8%, TCBI +2.6%, UL +2.3%, PPG +2.2%, DOV +2.1%, SYF +1.8%, OZK +1.4%, HON +1.3%, TRV +0.9%, SLB +0.8%, CCI +0.7%, CATY +0.7%, RF +0.7%, CFG +0.7%, PM +0.6%
Select cannabis related names showing strength:
- HEXO +5%, CGC +5%, PYX +3.5%, CRON +2.3%, MJ +1.9%, ACB +1.3%, NBEV +1%, TLRY +0.8%, .
Other news:
- MBIO +167.3% (St. Jude Children's Research Hospital publishes results of lentiviral gene therapy for treatment of infants with X-linked severe combined immunodeficiency), APHA +4.9% (prices offering of $300 mln of 5.25% convertible senior notes due 2024)
- VFF +3.2% (extending yesterday's 10% move higher)
- PBR +2.3% (being attributed to CFO comments suggesting the sale of new group of natural gas pipelines)
- WTR +2.2% (prices offering of 32,495,667 shares of its common stock at $34.62 per share)
- AFMD +1.4% (Affimed Therapeutics announces regulatory update on AFM11 clinical program)
- WYNN +1.3% (following LVS earnings), .
Analyst comments:
- ETRN +5% (initiated with a Sector Perform at RBC Capital Mkts)
- VNTR +4.8% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- NICE +0.7% (upgraded to Overweight from Neutral at JP Morgan)